PubRank
Search
About
Karthik Ramakrishnan
Author PubWeight™ 5.95
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Economic impact of therapeutic substitution of a brand selective serotonin reuptake inhibitor with an alternative generic selective serotonin reuptake inhibitor in patients with major depressive disorder.
Ann Pharmacother
2011
1.51
2
Therapy persistence and adherence in patients with chronic obstructive pulmonary disease: multiple versus single long-acting maintenance inhalers.
J Med Econ
2011
1.19
3
Clinical and economic outcomes of multiple versus single long-acting inhalers in COPD.
Respir Med
2011
0.90
4
Cardiovascular and economic outcomes after initiation of atorvastatin versus simvastatin in an employed population stratified by cardiovascular risk.
Am J Ther
2011
0.79
5
Effects of adalimumab versus placebo on risk of symptom worsening in psoriasis and subsequent impacts on health-related quality-of-life: analysis of pooled data from two randomized, double-blind, placebo-controlled, multicentre clinical trials.
Clin Drug Investig
2011
0.79
6
Persistence with nebivolol in the treatment of hypertension: a retrospective claims analysis.
Curr Med Res Opin
2012
0.77
7
Use of β-blockade and levosimendan for separation from extracorporeal life support in an infant with postoperative diastolic dysfunction.
World J Pediatr Congenit Heart Surg
2013
0.75
8
Benefit-risk analysis of adalimumab versus methotrexate and placebo in the treatment of moderate to severe psoriasis: comparison of adverse event-free response days in the CHAMPION trial.
J Am Acad Dermatol
2010
0.75
9
IV Versus Subcutaneous Enoxaparin in Critically Ill Infants and Children: Comparison of Dosing, Anticoagulation Quality, Efficacy, and Safety Outcomes.
Pediatr Crit Care Med
2017
0.75
10
Remission of major depressive disorder without adverse events: a comparison of escitalopram versus serotonin norepinephrine reuptake inhibitors.
Curr Med Res Opin
2011
0.75